XNYS
VEEV
Market cap30bUSD
Jul 09, Last price
189.70USD
1D
0.81%
1Q
25.27%
Jan 2017
366.09%
IPO
356.01%
Name
Veeva Systems Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Veeva Systems Inc. is a global provider of specialized cloud-based software solutions designed exclusively for the life sciences sector. Its reach extends across key regions including North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. Among its core offerings is the Veeva Commercial Cloud, a comprehensive platform integrating software, data, and analytics to optimize commercial operations. This suite comprises various modules such as Veeva CRM (including specialized Medical CRM), Veeva CLM, Veeva CRM MyInsights, Approved Email, Engage, Align, Events Management, Veeva Nitro, OpenData, Link, Network, Crossix, Data Cloud, and MyVeeva for Patients. Veeva also provides Veeva Vault, an enterprise-grade, cloud-based application suite for content and data management. Vault streamlines critical functions across both commercial and research & development domains. For commercial teams, this includes sales, marketing, and medical content and communications. On the R&D side, it addresses areas like clinical trials, regulatory affairs, quality assurance, and patient safety. Beyond its software products, Veeva offers a comprehensive array of professional and support services. These services span implementation planning, project management, requirements analysis, solution design, and system configuration. They also encompass managing system environments, facilitating business process transformation related to Veeva solutions, and providing technical consulting for data migration and system integrations. Additionally, the company delivers training on its platforms and offers ongoing managed services, including outsourced systems administration. Established in 2007, the company originally operated as Verticals onDemand, Inc. before rebranding as Veeva Systems Inc. in April 2009. Its corporate headquarters are located in Pleasanton, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑01 | 2025‑01 | 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||